SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the ...

Naturally, I received a wide range of responses, but more than anything, I saw responses like this: “The blatant Antisemitism that is allowed, and apparently encouraged in this country without ...

Revelation’s net income for the three months ended March 31, 2023 was $6.2 million, or $2.79 basic earnings per share and $1.96 diluted earnings per share, compared to a net loss of $6.6 million, or ...

How many times have we heard the phrase “We’ll pivot when we have to”? Bank failures, layoffs, coronations, new AIs like ChatGPT that seem to be an answer to everything…yeah, there’s a lot of ...